These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 10843168

  • 1. Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study.
    Vahl N, Juul A, Jørgensen JO, Orskov H, Skakkebaek NE, Christiansen JS.
    J Clin Endocrinol Metab; 2000 May; 85(5):1874-81. PubMed ID: 10843168
    [Abstract] [Full Text] [Related]

  • 2. Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism.
    Nørrelund H, Vahl N, Juul A, Møller N, Alberti KG, Skakkebaek NE, Christiansen JS, Jørgensen JO.
    J Clin Endocrinol Metab; 2000 May; 85(5):1912-7. PubMed ID: 10843174
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [Abstract] [Full Text] [Related]

  • 4. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.
    Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, Topliss D, Alford F, Hew L, Bode H, Conway A, Handelsman D, Dunn S, Boyages S, Cheung NW, Hurley D.
    J Clin Endocrinol Metab; 1998 Jan; 83(1):107-16. PubMed ID: 9435425
    [Abstract] [Full Text] [Related]

  • 5. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
    Carroll PV, Drake WM, Maher KT, Metcalfe K, Shaw NJ, Dunger DB, Cheetham TD, Camacho-Hübner C, Savage MO, Monson JP.
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3890-5. PubMed ID: 15292323
    [Abstract] [Full Text] [Related]

  • 6. Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial.
    Mauras N, Pescovitz OH, Allada V, Messig M, Wajnrajch MP, Lippe B, Transition Study Group.
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3946-55. PubMed ID: 15855257
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R, Bramnert M, Hägg E, Hilding A, Baylink DJ, Mohan S, Thorén M.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [Abstract] [Full Text] [Related]

  • 8. Discontinuing long-term GH replacement therapy--a randomized, placebo-controlled crossover trial in adult GH deficiency.
    Filipsson Nyström H, Barbosa EJ, Nilsson AG, Norrman LL, Ragnarsson O, Johannsson G.
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3185-95. PubMed ID: 22791760
    [Abstract] [Full Text] [Related]

  • 9. Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults--an 18-month randomised, placebo-controlled, double blinded trial.
    Sneppen SB, Hoeck HC, Kollerup G, Sørensen OH, Laurberg P, Feldt-Rasmussen U.
    Eur J Endocrinol; 2002 Feb; 146(2):187-95. PubMed ID: 11834427
    [Abstract] [Full Text] [Related]

  • 10. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group.
    Attanasio AF, Lamberts SW, Matranga AM, Birkett MA, Bates PC, Valk NK, Hilsted J, Bengtsson BA, Strasburger CJ.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):82-8. PubMed ID: 8989238
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study.
    Underwood LE, Attie KM, Baptista J, Genentech Collaborative Study Group.
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5273-80. PubMed ID: 14602761
    [Abstract] [Full Text] [Related]

  • 12. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy.
    Janssen JA, van der Toorn FM, Hofland LJ, van Koetsveld P, Broglio F, Ghigo E, Lamberts SW, Jan van der Lely A.
    Eur J Endocrinol; 2001 Dec; 145(6):711-6. PubMed ID: 11720895
    [Abstract] [Full Text] [Related]

  • 13. Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD).
    Pincelli AI, Bragato R, Scacchi M, Branzi G, Osculati G, Viarengo R, Leonetti G, Cavagnini F.
    J Endocrinol Invest; 2003 May; 26(5):420-8. PubMed ID: 12906369
    [Abstract] [Full Text] [Related]

  • 14. Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients.
    Attanasio AF, Howell S, Bates PC, Frewer P, Chipman J, Blum WF, Shalet SM.
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3368-72. PubMed ID: 12107251
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A, Kastrup KW, Pedersen SA, Skakkebaek NE.
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [Abstract] [Full Text] [Related]

  • 16. Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.
    Biller BM, Sesmilo G, Baum HB, Hayden D, Schoenfeld D, Klibanski A.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):970-6. PubMed ID: 10720025
    [Abstract] [Full Text] [Related]

  • 17. Gender-specific responses of lean body composition and non-gender-specific cardiac function improvement after GH replacement in GH-deficient adults.
    Ezzat S, Fear S, Gaillard RC, Gayle C, Landy H, Marcovitz S, Mattioni T, Nussey S, Rees A, Svanberg E.
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2725-33. PubMed ID: 12050241
    [Abstract] [Full Text] [Related]

  • 18. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.
    Johannsson G, Albertsson-Wikland K, Bengtsson BA.
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4516-24. PubMed ID: 10599711
    [Abstract] [Full Text] [Related]

  • 19. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [Abstract] [Full Text] [Related]

  • 20. The favourable effects of growth hormone (GH) substitution on hypercholesterolaemia in GH-deficient adults are not associated with concomitant reductions in adiposity. A 12 month placebo-controlled study.
    Vahl N, Jørgensen JO, Hansen TB, Klausen IB, Jurik AG, Hagen C, Christiansen JS.
    Int J Obes Relat Metab Disord; 1998 Jun; 22(6):529-36. PubMed ID: 9665673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.